CLINICAL_TRIALS
trial_result
· 2015-07-30
Clinical Trial Update: 20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms [Phase 2]
Summary
A Phase 2 trial evaluating AMG 747 for negative symptoms in schizophrenia was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Schizophrenia | Phase 2 | Status: TERMINATED